Zhihui Li

ORCID: 0000-0002-9872-7624 · 2 papers in corpus

review 2022

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy

Molecular biomedicine ·doi:10.1186/s43556-022-00110-2

The PI3K/AKT/mTOR and RAF/MEK/ERK pathways are commonly activated by mutations and chromosomal translocation in vital targets. The PI3K/AKT/mTOR signaling pathway is dysregulated in nearly all kinds of neoplasms, with the component in this …

lab-animal 2021

Molecular Targets and Associated Signaling Pathways of Jingshu Granules in Ovarian Cysts Based on Systemic Pharmacological Analysis

BioMed research international ·doi:10.1155/2021/6660087

BACKGROUND: More than a third of women could develop ovarian cysts during their lifetime. Jingshu granules are used for the treatment of gynecological disease of primary dysmenorrhea. However, the molecular mechanisms of Jingshu granules in…